+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Antimicrobial Suture Market By Type: Global Opportunity Analysis and Industry Forecast, 2024-2033

  • PDF Icon

    Report

  • 280 Pages
  • July 2024
  • Region: Global
  • Allied Market Research
  • ID: 5994255
Description Jump to:
The antimicrobial suture market was valued at $297.9 million in 2023 and is projected to reach $430.1 million by 2033, growing at a CAGR of 3.7% from 2024 to 2033.

An antimicrobial suture is a medical stitch macerated with chemical compounds which are toxic to bacteria. It is applied on wounds to prevent the growth of bacteria and reduce the chances of infection. The action mechanism of the chemical compound present in antimicrobial sutures involves interrupting the cell mechanisms of bacteria. Different surgical procedures such as general surgeries, cardiovascular surgeries, and orthopedic surgeries involve the application of sutures for wound healing. The sutures are essential for patients with high risk of infection, with compromised immune systems, or those undergoing lengthy surgical procedures.

Increase in awareness about the risk of infection over wounds or surgical sites is enhancing the adoption of antimicrobial sutures, thereby driving the growth of the market. In addition, the frequency of surgical procedures is increasing due to rise in prevalence of chronic diseases, exponential growth of aging population, and upsurge in the availability of medical facilities. These factors are boosting the demand for antimicrobial sutures. Currently, the usage of nanoengineering in the production of sutures is acquiring traction as the technique enhances their antimicrobial properties. The technique is further being utilized to design biodegradable sutures.

However, the higher cost of antimicrobial sutures as compared to the conventional stitches restricts their adoption, particularly in the healthcare settings with low budgets. In addition, several healthcare providers prefer conventional sutures over the advanced antimicrobial sutures due to the familiarity with its application, hence restraining the development of the market. On the contrary, the development of innovative smart sutures with enhanced attributes is anticipated to present novel growth opportunities for the market. Engineers from the Massachusetts Institute of Technology have designed a smart suture which releases drugs upon the detection of inflammation, along with holding the tissue in place. Derived from animal tissues, the suture encloses hydrogel integrated with drugs, cells, or sensors, which release the therapeutic molecules when necessary.

Segment Review

The antimicrobial suture market is segmented into type, end user, and region. On the basis of type, the market is bifurcated into absorbable and non-absorbable. As per end user, it is divided into hospitals, clinics, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

On the basis of type, the absorbable segment is expected to be the highest shareholder by 2033.

As per end user, the hospital segment dominated the market in 2023.

Region wise, North America was the highest revenue generator in 2023.

Competition Analysis

The leading players operating in the global antimicrobial suture market include W.L. Gore & Associates, Medtronic Inc., Johnson and Johnson, Sutures India Pvt Ltd., Lotus Surgicals, B. Braun Melsungen AG, Smith & Nephew plc, Boston Scientific Corporation, Demetech Corporation, and Conmed Corporation. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships, to strengthen their foothold in the competitive market.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Additional company profiles with specific to client's interest
  • Additional country or region analysis- market size and forecast

Key Market Segments

By Type

  • Absorbable
  • Non absorbable

By End User

  • Hospitals
  • Clinics
  • Others

By Region

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • France
  • Germany
  • Italy
  • Spain
  • UK
  • Rest of Europe
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia-Pacific
  • LAMEA
  • Brazil
  • South Africa
  • Saudi Arabia
  • Rest of LAMEA

Key Market Players

  • W.L. Gore & Associates
  • Medtronic Inc.,
  • Johnson and Johnson
  • Sutures India Pvt Ltd.
  • Lotus Surgicals
  • B. Braun Melsungen AG
  • Smith & Nephew plc
  • Boston Scientific Corporation
  • Demetech Corporation
  • Conmed Corporation

 

Please note:

  • Online Access price format is valid for 60 days access. Printing is not enabled.
  • PDF Single and Enterprise price formats enable printing.

 

Table of Contents

CHAPTER 1: INTRODUCTION
1.1. Report Description
1.2. Key Market Segments
1.3. Key Benefits
1.4. Research Methodology
1.4.1. Primary Research
1.4.2. Secondary Research
1.4.3. Analyst Tools and Models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET LANDSCAPE
3.1. Market Definition and Scope
3.2. Key Findings
3.2.1. Top Investment Pockets
3.2.2. Top Winning Strategies
3.3. Porter's Five Forces Analysis
3.3.1. Bargaining Power of Suppliers
3.3.2. Threat of New Entrants
3.3.3. Threat of Substitutes
3.3.4. Competitive Rivalry
3.3.5. Bargaining Power among Buyers
3.4. Market Dynamics
3.4.1. Drivers
3.4.2. Restraints
3.4.3. Opportunities
CHAPTER 4: ANTIMICROBIAL SUTURE MARKET, BY TYPE
4.1. Market Overview
4.1.1 Market Size and Forecast, By Type
4.2. Absorbable
4.2.1. Key Market Trends, Growth Factors and Opportunities
4.2.2. Market Size and Forecast, By Region
4.2.3. Market Share Analysis, By Country
4.3. Non Absorbable
4.3.1. Key Market Trends, Growth Factors and Opportunities
4.3.2. Market Size and Forecast, By Region
4.3.3. Market Share Analysis, By Country
CHAPTER 5: ANTIMICROBIAL SUTURE MARKET, BY END USER
5.1. Market Overview
5.1.1 Market Size and Forecast, By End User
5.2. Hospitals
5.2.1. Key Market Trends, Growth Factors and Opportunities
5.2.2. Market Size and Forecast, By Region
5.2.3. Market Share Analysis, By Country
5.3. Clinics
5.3.1. Key Market Trends, Growth Factors and Opportunities
5.3.2. Market Size and Forecast, By Region
5.3.3. Market Share Analysis, By Country
5.4. Others
5.4.1. Key Market Trends, Growth Factors and Opportunities
5.4.2. Market Size and Forecast, By Region
5.4.3. Market Share Analysis, By Country
CHAPTER 6: ANTIMICROBIAL SUTURE MARKET, BY REGION
6.1. Market Overview
6.1.1 Market Size and Forecast, By Region
6.2. North America
6.2.1. Key Market Trends and Opportunities
6.2.2. Market Size and Forecast, By Type
6.2.3. Market Size and Forecast, By End User
6.2.4. Market Size and Forecast, By Country
6.2.5. U.S. Antimicrobial Suture Market
6.2.5.1. Market Size and Forecast, By Type
6.2.5.2. Market Size and Forecast, By End User
6.2.6. Canada Antimicrobial Suture Market
6.2.6.1. Market Size and Forecast, By Type
6.2.6.2. Market Size and Forecast, By End User
6.2.7. Mexico Antimicrobial Suture Market
6.2.7.1. Market Size and Forecast, By Type
6.2.7.2. Market Size and Forecast, By End User
6.3. Europe
6.3.1. Key Market Trends and Opportunities
6.3.2. Market Size and Forecast, By Type
6.3.3. Market Size and Forecast, By End User
6.3.4. Market Size and Forecast, By Country
6.3.5. France Antimicrobial Suture Market
6.3.5.1. Market Size and Forecast, By Type
6.3.5.2. Market Size and Forecast, By End User
6.3.6. Germany Antimicrobial Suture Market
6.3.6.1. Market Size and Forecast, By Type
6.3.6.2. Market Size and Forecast, By End User
6.3.7. Italy Antimicrobial Suture Market
6.3.7.1. Market Size and Forecast, By Type
6.3.7.2. Market Size and Forecast, By End User
6.3.8. Spain Antimicrobial Suture Market
6.3.8.1. Market Size and Forecast, By Type
6.3.8.2. Market Size and Forecast, By End User
6.3.9. UK Antimicrobial Suture Market
6.3.9.1. Market Size and Forecast, By Type
6.3.9.2. Market Size and Forecast, By End User
6.3.10. Rest Of Europe Antimicrobial Suture Market
6.3.10.1. Market Size and Forecast, By Type
6.3.10.2. Market Size and Forecast, By End User
6.4. Asia-Pacific
6.4.1. Key Market Trends and Opportunities
6.4.2. Market Size and Forecast, By Type
6.4.3. Market Size and Forecast, By End User
6.4.4. Market Size and Forecast, By Country
6.4.5. China Antimicrobial Suture Market
6.4.5.1. Market Size and Forecast, By Type
6.4.5.2. Market Size and Forecast, By End User
6.4.6. Japan Antimicrobial Suture Market
6.4.6.1. Market Size and Forecast, By Type
6.4.6.2. Market Size and Forecast, By End User
6.4.7. India Antimicrobial Suture Market
6.4.7.1. Market Size and Forecast, By Type
6.4.7.2. Market Size and Forecast, By End User
6.4.8. South Korea Antimicrobial Suture Market
6.4.8.1. Market Size and Forecast, By Type
6.4.8.2. Market Size and Forecast, By End User
6.4.9. Australia Antimicrobial Suture Market
6.4.9.1. Market Size and Forecast, By Type
6.4.9.2. Market Size and Forecast, By End User
6.4.10. Rest of Asia-Pacific Antimicrobial Suture Market
6.4.10.1. Market Size and Forecast, By Type
6.4.10.2. Market Size and Forecast, By End User
6.5. LAMEA
6.5.1. Key Market Trends and Opportunities
6.5.2. Market Size and Forecast, By Type
6.5.3. Market Size and Forecast, By End User
6.5.4. Market Size and Forecast, By Country
6.5.5. Brazil Antimicrobial Suture Market
6.5.5.1. Market Size and Forecast, By Type
6.5.5.2. Market Size and Forecast, By End User
6.5.6. South Africa Antimicrobial Suture Market
6.5.6.1. Market Size and Forecast, By Type
6.5.6.2. Market Size and Forecast, By End User
6.5.7. Saudi Arabia Antimicrobial Suture Market
6.5.7.1. Market Size and Forecast, By Type
6.5.7.2. Market Size and Forecast, By End User
6.5.8. Rest of LAMEA Antimicrobial Suture Market
6.5.8.1. Market Size and Forecast, By Type
6.5.8.2. Market Size and Forecast, By End User
CHAPTER 7: COMPETITIVE LANDSCAPE
7.1. Introduction
7.2. Top Winning Strategies
7.3. Product Mapping Of Top 10 Player
7.4. Competitive Dashboard
7.5. Competitive Heatmap
7.6. Top Player Positioning, 2023
CHAPTER 8: COMPANY PROFILES
8.1. W.L. Gore And Associates
8.1.1. Company Overview
8.1.2. Key Executives
8.1.3. Company Snapshot
8.1.4. Operating Business Segments
8.1.5. Product Portfolio
8.1.6. Business Performance
8.1.7. Key Strategic Moves and Developments
8.2. Medtronic Inc.,
8.2.1. Company Overview
8.2.2. Key Executives
8.2.3. Company Snapshot
8.2.4. Operating Business Segments
8.2.5. Product Portfolio
8.2.6. Business Performance
8.2.7. Key Strategic Moves and Developments
8.3. Johnson And Johnson
8.3.1. Company Overview
8.3.2. Key Executives
8.3.3. Company Snapshot
8.3.4. Operating Business Segments
8.3.5. Product Portfolio
8.3.6. Business Performance
8.3.7. Key Strategic Moves and Developments
8.4. Sutures India Pvt Ltd.
8.4.1. Company Overview
8.4.2. Key Executives
8.4.3. Company Snapshot
8.4.4. Operating Business Segments
8.4.5. Product Portfolio
8.4.6. Business Performance
8.4.7. Key Strategic Moves and Developments
8.5. Lotus Surgicals
8.5.1. Company Overview
8.5.2. Key Executives
8.5.3. Company Snapshot
8.5.4. Operating Business Segments
8.5.5. Product Portfolio
8.5.6. Business Performance
8.5.7. Key Strategic Moves and Developments
8.6. B. Braun Melsungen AG
8.6.1. Company Overview
8.6.2. Key Executives
8.6.3. Company Snapshot
8.6.4. Operating Business Segments
8.6.5. Product Portfolio
8.6.6. Business Performance
8.6.7. Key Strategic Moves and Developments
8.7. Smith And Nephew Plc
8.7.1. Company Overview
8.7.2. Key Executives
8.7.3. Company Snapshot
8.7.4. Operating Business Segments
8.7.5. Product Portfolio
8.7.6. Business Performance
8.7.7. Key Strategic Moves and Developments
8.8. Boston Scientific Corporation
8.8.1. Company Overview
8.8.2. Key Executives
8.8.3. Company Snapshot
8.8.4. Operating Business Segments
8.8.5. Product Portfolio
8.8.6. Business Performance
8.8.7. Key Strategic Moves and Developments
8.9. Demetech Corporation
8.9.1. Company Overview
8.9.2. Key Executives
8.9.3. Company Snapshot
8.9.4. Operating Business Segments
8.9.5. Product Portfolio
8.9.6. Business Performance
8.9.7. Key Strategic Moves and Developments
8.10. Conmed Corporation
8.10.1. Company Overview
8.10.2. Key Executives
8.10.3. Company Snapshot
8.10.4. Operating Business Segments
8.10.5. Product Portfolio
8.10.6. Business Performance
8.10.7. Key Strategic Moves and Developments
LIST OF TABLES
TABLE 1. GLOBAL ANTIMICROBIAL SUTURE MARKET, BY TYPE, 2024 - 2033 ($MILLION)
TABLE 2. ANTIMICROBIAL SUTURE MARKET FOR ABSORBABLE, BY REGION, 2024 - 2033 ($MILLION)
TABLE 3. ANTIMICROBIAL SUTURE MARKET FOR NON ABSORBABLE, BY REGION, 2024 - 2033 ($MILLION)
TABLE 4. GLOBAL ANTIMICROBIAL SUTURE MARKET, BY END USER, 2024 - 2033 ($MILLION)
TABLE 5. ANTIMICROBIAL SUTURE MARKET FOR HOSPITALS, BY REGION, 2024 - 2033 ($MILLION)
TABLE 6. ANTIMICROBIAL SUTURE MARKET FOR CLINICS, BY REGION, 2024 - 2033 ($MILLION)
TABLE 7. ANTIMICROBIAL SUTURE MARKET FOR OTHERS, BY REGION, 2024 - 2033 ($MILLION)
TABLE 8. ANTIMICROBIAL SUTURE MARKET, BY REGION, 2024 - 2033 ($MILLION)
TABLE 9. NORTH AMERICA ANTIMICROBIAL SUTURE MARKET, BY COUNTRY, 2024 - 2033 ($MILLION)
TABLE 10. NORTH AMERICA ANTIMICROBIAL SUTURE MARKET, BY TYPE, 2024 - 2033 ($MILLION)
TABLE 11. NORTH AMERICA ANTIMICROBIAL SUTURE MARKET, BY END USER, 2024 - 2033 ($MILLION)
TABLE 12. U.S. ANTIMICROBIAL SUTURE MARKET, BY TYPE, 2024 - 2033 ($MILLION)
TABLE 13. U.S. ANTIMICROBIAL SUTURE MARKET, BY END USER, 2024 - 2033 ($MILLION)
TABLE 14. CANADA ANTIMICROBIAL SUTURE MARKET, BY TYPE, 2024 - 2033 ($MILLION)
TABLE 15. CANADA ANTIMICROBIAL SUTURE MARKET, BY END USER, 2024 - 2033 ($MILLION)
TABLE 16. MEXICO ANTIMICROBIAL SUTURE MARKET, BY TYPE, 2024 - 2033 ($MILLION)
TABLE 17. MEXICO ANTIMICROBIAL SUTURE MARKET, BY END USER, 2024 - 2033 ($MILLION)
TABLE 18. EUROPE ANTIMICROBIAL SUTURE MARKET, BY COUNTRY, 2024 - 2033 ($MILLION)
TABLE 19. EUROPE ANTIMICROBIAL SUTURE MARKET, BY TYPE, 2024 - 2033 ($MILLION)
TABLE 20. EUROPE ANTIMICROBIAL SUTURE MARKET, BY END USER, 2024 - 2033 ($MILLION)
TABLE 21. FRANCE ANTIMICROBIAL SUTURE MARKET, BY TYPE, 2024 - 2033 ($MILLION)
TABLE 22. FRANCE ANTIMICROBIAL SUTURE MARKET, BY END USER, 2024 - 2033 ($MILLION)
TABLE 23. GERMANY ANTIMICROBIAL SUTURE MARKET, BY TYPE, 2024 - 2033 ($MILLION)
TABLE 24. GERMANY ANTIMICROBIAL SUTURE MARKET, BY END USER, 2024 - 2033 ($MILLION)
TABLE 25. ITALY ANTIMICROBIAL SUTURE MARKET, BY TYPE, 2024 - 2033 ($MILLION)
TABLE 26. ITALY ANTIMICROBIAL SUTURE MARKET, BY END USER, 2024 - 2033 ($MILLION)
TABLE 27. SPAIN ANTIMICROBIAL SUTURE MARKET, BY TYPE, 2024 - 2033 ($MILLION)
TABLE 28. SPAIN ANTIMICROBIAL SUTURE MARKET, BY END USER, 2024 - 2033 ($MILLION)
TABLE 29. UK ANTIMICROBIAL SUTURE MARKET, BY TYPE, 2024 - 2033 ($MILLION)
TABLE 30. UK ANTIMICROBIAL SUTURE MARKET, BY END USER, 2024 - 2033 ($MILLION)
TABLE 31. REST OF EUROPE ANTIMICROBIAL SUTURE MARKET, BY TYPE, 2024 - 2033 ($MILLION)
TABLE 32. REST OF EUROPE ANTIMICROBIAL SUTURE MARKET, BY END USER, 2024 - 2033 ($MILLION)
TABLE 33. ASIA-PACIFIC ANTIMICROBIAL SUTURE MARKET, BY COUNTRY, 2024 - 2033 ($MILLION)
TABLE 34. ASIA-PACIFIC ANTIMICROBIAL SUTURE MARKET, BY TYPE, 2024 - 2033 ($MILLION)
TABLE 35. ASIA-PACIFIC ANTIMICROBIAL SUTURE MARKET, BY END USER, 2024 - 2033 ($MILLION)
TABLE 36. CHINA ANTIMICROBIAL SUTURE MARKET, BY TYPE, 2024 - 2033 ($MILLION)
TABLE 37. CHINA ANTIMICROBIAL SUTURE MARKET, BY END USER, 2024 - 2033 ($MILLION)
TABLE 38. JAPAN ANTIMICROBIAL SUTURE MARKET, BY TYPE, 2024 - 2033 ($MILLION)
TABLE 39. JAPAN ANTIMICROBIAL SUTURE MARKET, BY END USER, 2024 - 2033 ($MILLION)
TABLE 40. INDIA ANTIMICROBIAL SUTURE MARKET, BY TYPE, 2024 - 2033 ($MILLION)
TABLE 41. INDIA ANTIMICROBIAL SUTURE MARKET, BY END USER, 2024 - 2033 ($MILLION)
TABLE 42. SOUTH KOREA ANTIMICROBIAL SUTURE MARKET, BY TYPE, 2024 - 2033 ($MILLION)
TABLE 43. SOUTH KOREA ANTIMICROBIAL SUTURE MARKET, BY END USER, 2024 - 2033 ($MILLION)
TABLE 44. AUSTRALIA ANTIMICROBIAL SUTURE MARKET, BY TYPE, 2024 - 2033 ($MILLION)
TABLE 45. AUSTRALIA ANTIMICROBIAL SUTURE MARKET, BY END USER, 2024 - 2033 ($MILLION)
TABLE 46. REST OF ASIA-PACIFIC ANTIMICROBIAL SUTURE MARKET, BY TYPE, 2024 - 2033 ($MILLION)
TABLE 47. REST OF ASIA-PACIFIC ANTIMICROBIAL SUTURE MARKET, BY END USER, 2024 - 2033 ($MILLION)
TABLE 48. LAMEA ANTIMICROBIAL SUTURE MARKET, BY COUNTRY, 2024 - 2033 ($MILLION)
TABLE 49. LAMEA ANTIMICROBIAL SUTURE MARKET, BY TYPE, 2024 - 2033 ($MILLION)
TABLE 50. LAMEA ANTIMICROBIAL SUTURE MARKET, BY END USER, 2024 - 2033 ($MILLION)
TABLE 51. BRAZIL ANTIMICROBIAL SUTURE MARKET, BY TYPE, 2024 - 2033 ($MILLION)
TABLE 52. BRAZIL ANTIMICROBIAL SUTURE MARKET, BY END USER, 2024 - 2033 ($MILLION)
TABLE 53. SOUTH AFRICA ANTIMICROBIAL SUTURE MARKET, BY TYPE, 2024 - 2033 ($MILLION)
TABLE 54. SOUTH AFRICA ANTIMICROBIAL SUTURE MARKET, BY END USER, 2024 - 2033 ($MILLION)
TABLE 55. SAUDI ARABIA ANTIMICROBIAL SUTURE MARKET, BY TYPE, 2024 - 2033 ($MILLION)
TABLE 56. SAUDI ARABIA ANTIMICROBIAL SUTURE MARKET, BY END USER, 2024 - 2033 ($MILLION)
TABLE 57. REST OF LAMEA ANTIMICROBIAL SUTURE MARKET, BY TYPE, 2024 - 2033 ($MILLION)
TABLE 58. REST OF LAMEA ANTIMICROBIAL SUTURE MARKET, BY END USER, 2024 - 2033 ($MILLION)
TABLE 59. W.L. GORE AND ASSOCIATES: KEY EXECUTIVES
TABLE 60. W.L. GORE AND ASSOCIATES: COMPANY SNAPSHOT
TABLE 61. W.L. GORE AND ASSOCIATES: OPERATING SEGMENTS
TABLE 62. W.L. GORE AND ASSOCIATES: PRODUCT PORTFOLIO
TABLE 63. W.L. GORE AND ASSOCIATES: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 64. MEDTRONIC INC., : KEY EXECUTIVES
TABLE 65. MEDTRONIC INC., : COMPANY SNAPSHOT
TABLE 66. MEDTRONIC INC., : OPERATING SEGMENTS
TABLE 67. MEDTRONIC INC., : PRODUCT PORTFOLIO
TABLE 68. MEDTRONIC INC., : KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 69. JOHNSON AND JOHNSON: KEY EXECUTIVES
TABLE 70. JOHNSON AND JOHNSON: COMPANY SNAPSHOT
TABLE 71. JOHNSON AND JOHNSON: OPERATING SEGMENTS
TABLE 72. JOHNSON AND JOHNSON: PRODUCT PORTFOLIO
TABLE 73. JOHNSON AND JOHNSON: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 74. SUTURES INDIA PVT LTD.: KEY EXECUTIVES
TABLE 75. SUTURES INDIA PVT LTD.: COMPANY SNAPSHOT
TABLE 76. SUTURES INDIA PVT LTD.: OPERATING SEGMENTS
TABLE 77. SUTURES INDIA PVT LTD.: PRODUCT PORTFOLIO
TABLE 78. SUTURES INDIA PVT LTD.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 79. LOTUS SURGICALS: KEY EXECUTIVES
TABLE 80. LOTUS SURGICALS: COMPANY SNAPSHOT
TABLE 81. LOTUS SURGICALS: OPERATING SEGMENTS
TABLE 82. LOTUS SURGICALS: PRODUCT PORTFOLIO
TABLE 83. LOTUS SURGICALS: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 84. B. BRAUN MELSUNGEN AG: KEY EXECUTIVES
TABLE 85. B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT
TABLE 86. B. BRAUN MELSUNGEN AG: OPERATING SEGMENTS
TABLE 87. B. BRAUN MELSUNGEN AG: PRODUCT PORTFOLIO
TABLE 88. B. BRAUN MELSUNGEN AG: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 89. SMITH AND NEPHEW PLC: KEY EXECUTIVES
TABLE 90. SMITH AND NEPHEW PLC: COMPANY SNAPSHOT
TABLE 91. SMITH AND NEPHEW PLC: OPERATING SEGMENTS
TABLE 92. SMITH AND NEPHEW PLC: PRODUCT PORTFOLIO
TABLE 93. SMITH AND NEPHEW PLC: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 94. BOSTON SCIENTIFIC CORPORATION: KEY EXECUTIVES
TABLE 95. BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT
TABLE 96. BOSTON SCIENTIFIC CORPORATION: OPERATING SEGMENTS
TABLE 97. BOSTON SCIENTIFIC CORPORATION: PRODUCT PORTFOLIO
TABLE 98. BOSTON SCIENTIFIC CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 99. DEMETECH CORPORATION: KEY EXECUTIVES
TABLE 100. DEMETECH CORPORATION: COMPANY SNAPSHOT
TABLE 101. DEMETECH CORPORATION: OPERATING SEGMENTS
TABLE 102. DEMETECH CORPORATION: PRODUCT PORTFOLIO
TABLE 103. DEMETECH CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 104. CONMED CORPORATION: KEY EXECUTIVES
TABLE 105. CONMED CORPORATION: COMPANY SNAPSHOT
TABLE 106. CONMED CORPORATION: OPERATING SEGMENTS
TABLE 107. CONMED CORPORATION: PRODUCT PORTFOLIO
TABLE 108. CONMED CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
LIST OF FIGURES
FIGURE 1. GLOBAL ANTIMICROBIAL SUTURE MARKET, 2024 - 2033
FIGURE 2. SEGMENTATION OF ANTIMICROBIAL SUTURE MARKET, 2024 - 2033
FIGURE 3. TOP INVESTMENT POCKET IN ANTIMICROBIAL SUTURE MARKET
FIGURE 4. MODERATE BARGAINING POWER OF BUYERS
FIGURE 5. MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 6. MODERATE THREAT OF NEW ENTRANTS
FIGURE 7. LOW THREAT OF SUBSTITUTION
FIGURE 8. HIGH COMPETITIVE RIVALRY
FIGURE 9. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALANTIMICROBIAL SUTURE MARKET
FIGURE 10. GLOBAL ANTIMICROBIAL SUTURE MARKET SEGMENTATION, BY TYPE
FIGURE 11. ANTIMICROBIAL SUTURE MARKET FOR ABSORBABLE, BY COUNTRY, 2024 - 2033 ($MILLION)
FIGURE 12. ANTIMICROBIAL SUTURE MARKET FOR NON ABSORBABLE, BY COUNTRY, 2024 - 2033 ($MILLION)
FIGURE 13. GLOBAL ANTIMICROBIAL SUTURE MARKET SEGMENTATION, BY END USER
FIGURE 14. ANTIMICROBIAL SUTURE MARKET FOR HOSPITALS, BY COUNTRY, 2024 - 2033 ($MILLION)
FIGURE 15. ANTIMICROBIAL SUTURE MARKET FOR CLINICS, BY COUNTRY, 2024 - 2033 ($MILLION)
FIGURE 16. ANTIMICROBIAL SUTURE MARKET FOR OTHERS, BY COUNTRY, 2024 - 2033 ($MILLION)
FIGURE 17. TOP WINNING STRATEGIES, BY YEAR, 2021-2023*
FIGURE 18. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2021-2023*
FIGURE 19. TOP WINNING STRATEGIES, BY COMPANY, 2021-2023*
FIGURE 20. PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 21. COMPETITIVE DASHBOARD
FIGURE 22. COMPETITIVE HEATMAP: ANTIMICROBIAL SUTURE MARKET
FIGURE 23. TOP PLAYER POSITIONING, 2023
FIGURE 24. W.L. GORE AND ASSOCIATES: NET SALES, 2021-2023 ($MILLION)
FIGURE 25. W.L. GORE AND ASSOCIATES: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 26. W.L. GORE AND ASSOCIATES: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 27. MEDTRONIC INC., : NET SALES, 2021-2023 ($MILLION)
FIGURE 28. MEDTRONIC INC., : REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 29. MEDTRONIC INC., : REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 30. JOHNSON AND JOHNSON: NET SALES, 2021-2023 ($MILLION)
FIGURE 31. JOHNSON AND JOHNSON: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 32. JOHNSON AND JOHNSON: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 33. SUTURES INDIA PVT LTD.: NET SALES, 2021-2023 ($MILLION)
FIGURE 34. SUTURES INDIA PVT LTD.: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 35. SUTURES INDIA PVT LTD.: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 36. LOTUS SURGICALS: NET SALES, 2021-2023 ($MILLION)
FIGURE 37. LOTUS SURGICALS: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 38. LOTUS SURGICALS: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 39. B. BRAUN MELSUNGEN AG: NET SALES, 2021-2023 ($MILLION)
FIGURE 40. B. BRAUN MELSUNGEN AG: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 41. B. BRAUN MELSUNGEN AG: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 42. SMITH AND NEPHEW PLC: NET SALES, 2021-2023 ($MILLION)
FIGURE 43. SMITH AND NEPHEW PLC: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 44. SMITH AND NEPHEW PLC: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 45. BOSTON SCIENTIFIC CORPORATION: NET SALES, 2021-2023 ($MILLION)
FIGURE 46. BOSTON SCIENTIFIC CORPORATION: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 47. BOSTON SCIENTIFIC CORPORATION: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 48. DEMETECH CORPORATION: NET SALES, 2021-2023 ($MILLION)
FIGURE 49. DEMETECH CORPORATION: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 50. DEMETECH CORPORATION: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 51. CONMED CORPORATION: NET SALES, 2021-2023 ($MILLION)
FIGURE 52. CONMED CORPORATION: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 53. CONMED CORPORATION: REVENUE SHARE, BY REGION, 2023 (%)

Companies Mentioned

  • W.L. Gore & Associates
  • Medtronic Inc.,
  • Johnson and Johnson
  • Sutures India Pvt Ltd.
  • Lotus Surgicals
  • B. Braun Melsungen AG
  • Smith & Nephew plc
  • Boston Scientific Corporation
  • Demetech Corporation
  • Conmed Corporation

Methodology

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages280
PublishedJuly 2024
Forecast Period2023 - 2033
Estimated Market Value ( USD ) in 2023 $ 297.9 million
Forecasted Market Value ( USD ) by 2033 $ 430.1 million
Compound Annual Growth Rate3.7%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Antimicrobial Suture Market Size, Share & Trends Analysis Report by Type (Absorbable and Non Absorbable), End User (Hospitals, Clinics, and Others), Regional Outlook and Forecast, 2024-2031 - Product Image

Antimicrobial Suture Market Size, Share & Trends Analysis Report by Type (Absorbable and Non Absorbable), End User (Hospitals, Clinics, and Others), Regional Outlook and Forecast, 2024-2031

  • Report
  • 183 Pages
  • Global
From
Global Surgical Sutures Market: Focus on Applications, End Users, Products, Types and Over 14 Countries' Data - Analysis and Forecast, 2024-2033 - Product Image

Global Surgical Sutures Market: Focus on Applications, End Users, Products, Types and Over 14 Countries' Data - Analysis and Forecast, 2024-2033

  • Report
  • 155 Pages
  • Global
From
Surgical Sutures Market by Product (Automated Suturing Device (Disposable, Reuse), Suture Thread (Natural, Polypropylene, Stainless Steel, Antimicrobial)), Application (Cardiac, Gynae, Cosmetic, Ortho), End User & Region - Global Forecast to 2028 - Product Image

Surgical Sutures Market by Product (Automated Suturing Device (Disposable, Reuse), Suture Thread (Natural, Polypropylene, Stainless Steel, Antimicrobial)), Application (Cardiac, Gynae, Cosmetic, Ortho), End User & Region - Global Forecast to 2028

  • Report
  • 254 Pages
  • Global
From
Surgical Sutures And Staples Global Market Report 2024 - Product Image

Surgical Sutures And Staples Global Market Report 2024

  • Report
  • 250 Pages
  • Global
From
Cardiac Sutures Global Market Report 2024 - Product Image

Cardiac Sutures Global Market Report 2024

  • Report
  • 200 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.